Navigation Links
Two New Imaging Studies Show Higher Dose Lipitor Stopped the,Progression of Atherosclerosis

SPARCL Study

The SPARCL study, published in the New England Journal of Medicine in 2006, is the only study to date evaluating the benefits of a statin solely in patients with a prior stroke or mini-stroke (n=4,731). Lipitor 80 mg reduced the risk of an additional stroke by 16 percent and major coronary events by 35 percent compared with placebo. In a post-hoc analysis of the SPARCL trial, there was a higher incidence of hemorrhagic stroke in patients taking Lipitor 80 mg compared with patients taking placebo. Patients with prior hemorrhagic stroke at study entry appeared to be at an increased risk of hemorrhagic stroke.

In SPARCL, Lipitor was well-tolerated. The rate of side effects such as elevated liver enzymes, muscle weakness or rhabdomyolysis were low and consistent with the known safety profile.

Important U.S. Prescribing Information

Lipitor is a prescription medication. It is used in patients with multiple risk factors for heart disease such as family history, high blood pressure, age, low HDL ("good" cholesterol) or smoking to reduce the risk of a heart attack, stroke, certain types of heart surgery and chest pain.

Lipitor is also used in patients with type 2 diabetes and at least one other risk factor for heart disease such as high blood pressure, smoking or complications of diabetes, including eye disease and protein in urine, to reduce the risk of heart attack and stroke.

Lipitor is used in patients with existing coronary heart disease to reduce the risk of heart attack, stroke, certain kinds of heart surgery, hospitalization for heart failure, and chest pain. Lipitor is not indicated for atherosclerosis.

When diet and exercise alone are not enough, Lipitor is used along with a low-fat diet and exercise to lower cholesterol.

Lipitor is not for everyone. It is not for those with liver problems. And it is not for women who are nursing, pregnant or may become pregnant.

Patients taking Lipitor sho
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
2. Repligen Reports Positive Phase 2 Clinical Trial Results of Secretin for MRI Imaging of the Pancreas
3. Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimers Disease Presented at AD/PD Meeting
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
6. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
7. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
8. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
9. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
10. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
11. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
Post Your Comments:
(Date:5/1/2015)... 1, 2015  Legendary actor and director Danny ... PBAFacts campaign designed to educate and encourage patients with ... Pseudobulbar Affect (PBA) and to speak with their physician. ... has the ability to cry and laugh on cue ... experienced by people living with PBA episodes. ...
(Date:5/1/2015)... , May 1, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets products that assist ... today reported financial results for the first quarter ended ... quarter of 2015, Semler reported continued progress with year ... quarter revenue growth of 14%," said Doug Murphy-Chutorian ...
(Date:5/1/2015)... RUTHERFORD, N.J., May 1, 2015 Cambrex Corporation (NYSE: ... March 31, 2015. Highlights , ... and increased 27% excluding foreign currency impact, driven by Innovator ... million from $8.4 million in the first quarter of 2014. ... versus $0.04 in the first quarter last year and Adjusted ...
Breaking Medicine Technology:Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11
... the American Diabetes ... Association 68th Scientific Sessions, SAN FRANCISCO, June 7 ... today at the American Diabetes,Association (ADA) 68th Scientific Sessions by ... shown to be a highly,selective inhibitor of dipeptidyl peptidase-4 (DPP-4), ...
... SAN FRANCISCO, California, June 6 , - ... results from the world,s largest ever study of ... using modified release,gliclazide and other drugs as required, ... particular, intensive treatment reduces,the risk of kidney disease ...
Cached Medicine Technology:Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add-on Therapy Studies 2Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add-on Therapy Studies 3Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add-on Therapy Studies 4The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications 2
(Date:5/1/2015)... May 01, 2015 Royal River Natural ... Maine, reports on a new study that found two ... swelling and improved physical function as well as standard ... osteoarthritis of the knee. , The report is part ... for Well Being® ,” which Royal River Natural Foods ...
(Date:5/1/2015)... It’s raining bills on Capitol Hill with members in both ... for telemedicine. , “Such action is unprecedented in ... said Jonathan Linkous, CEO of the American Telemedicine Association (ATA). ... embrace the use of telecommunications in the delivery of care. ... to improve quality, access, equity and affordability of healthcare.”, ...
(Date:5/1/2015)... The fields of genetics and genomics, ... of genes with one another and the environment, is ... , LabRoots, the premier producer of interactive virtual events ... host its annual conference spotlighting the recent advances in ... and Genomics 2015 , a two-day event presented entirely ...
(Date:5/1/2015)... 01, 2015 As the sale of ... 18-month anniversary, many people in the industry are looking ... According the latest annual report by the ArcView ... in 2014, and reached nearly $3 billion in combined ... affair with cannabis, combined with the ongoing economic recovery, ...
(Date:5/1/2015)... VA (PRWEB) May 01, 2015 On May ... Mexican celebration of Cinco de Mayo with a twist. ... of two 12 ounce or one 24 ounce frozen yogurt ... de Mayo celebration originated in 1862 in commemoration of a ... in Mexico and the United States, but events are also ...
Breaking Medicine News(10 mins):Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 3Health News:sweetFrog to Celebrate Cinco de Mayo with a Yogurt Twist 2
... Rebuilding Revenue Base While Stabilizing Costs--, TSX ... - Vancouver, BC, Canada - Neovasc Inc. (TSXV: NVC), today ... 2009. , "The first quarter continued to show financial effects ... on our most promising growth areas," said Alexei Marko, chief ...
... for Recently Introduced MicroRNA-based Diagnostics Also Unveiled , ... a specialty pharmaceutical and diagnostic company, presented an overview ... American Society of Clinical Oncology (ASCO) Annual Meeting in ... of Receptor Tyrosine Kinases (RTK) Activation in Circulating Tumor ...
... PITTSBURGH, June 1 Since one child in 20 will have ... many young people will experience a Father,s Day without dad on ... to help ease the pain at this time, the Highmark Caring ... programs and services as well as online tools at no cost. ...
... A panoramic downtown Milwaukee view, lush greenery ... rooftop healing garden at Aurora St. Luke,s Medical ... awaiting guests at the newly opened Vince Lombardi ... Morland Hamilton Healing Conservatory. , , (Logo: ...
... ... based on scientific evidence, not marketing muscle or claims. CX3, Max Muscle Sports ... , ... (PRWEB) June 1, 2009 -- Creatine is perhaps one of the most widely used ...
... Contact an SSDI representation ... for initial applications will jump by 20 percent this year , ... Belleville, IL (Vocus) June 1, 2009 -- The Social Security Disability Insurance ... the next couple of years. This will make it even more important for people to find ...
Cached Medicine News:Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 2Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 3Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 4Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 5Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 6Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 7Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 8Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 9Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 10Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 11Health News:Prometheus Presents Proprietary Oncology Diagnostic Platform at ASCO Annual Meeting 2Health News:Prometheus Presents Proprietary Oncology Diagnostic Platform at ASCO Annual Meeting 3Health News:Easing the Pain of Father's Day Without Dad, Highmark Caring Place Helps Children Cope With the Death of a Parent 2Health News:Easing the Pain of Father's Day Without Dad, Highmark Caring Place Helps Children Cope With the Death of a Parent 3Health News:Aurora St. Luke's Dedicates Rooftop Healing Garden and Conservatory 2Health News:Aurora St. Luke's Dedicates Rooftop Healing Garden and Conservatory 3Health News:Max Muscle Sports Nutrition Releases The Truth About Creatine 2Health News:Max Muscle Sports Nutrition Releases The Truth About Creatine 3Health News:Max Muscle Sports Nutrition Releases The Truth About Creatine 4Health News:Social Security Disability Backlog Worsens, So Make Sure You Qualify Before You Apply 2Health News:Social Security Disability Backlog Worsens, So Make Sure You Qualify Before You Apply 3Health News:Social Security Disability Backlog Worsens, So Make Sure You Qualify Before You Apply 4Health News:Social Security Disability Backlog Worsens, So Make Sure You Qualify Before You Apply 5
...
...
...
... employs titanium alloy plasma spray porous ... surface. Biomet's ArCom processed polyethylene is ... bearing material. The Maxim Knee System's ... tibial components offer excellent sizing options ...
Medicine Products: